Sirnaomics Ltd. 2257.HK Stock
Sirnaomics Ltd. Price Chart
Sirnaomics Ltd. 2257.HK Financial and Trading Overview
| Sirnaomics Ltd. stock price | 5.99 HKD |
| Previous Close | 48.55 HKD |
| Open | 48.55 HKD |
| Bid | 48.55 HKD x N/A |
| Ask | 48.6 HKD x N/A |
| Day's Range | 48.3 - 49.15 HKD |
| 52 Week Range | 44.45 - 90.75 HKD |
| Volume | 54.6K HKD |
| Avg. Volume | 121.21K HKD |
| Market Cap | 4.29B HKD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.07 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.29 HKD |
2257.HK Valuation Measures
| Enterprise Value | 4.19B HKD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 164844.1 |
| Price/Book (mrq) | 34.964027 |
| Enterprise Value/Revenue | 161025.81 |
| Enterprise Value/EBITDA | -47.062 |
Trading Information
Sirnaomics Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -40.68% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 90.75 HKD |
| 52 Week Low | 44.45 HKD |
| 50-Day Moving Average | 52.37 HKD |
| 200-Day Moving Average | 57.34 HKD |
2257.HK Share Statistics
| Avg. Volume (3 month) | 121.21K HKD |
| Avg. Daily Volume (10-Days) | 78.81K HKD |
| Shares Outstanding | 88.19M |
| Float | 63.81M |
| Short Ratio | N/A |
| % Held by Insiders | 31.13% |
| % Held by Institutions | 3.90% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -350273.070% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.13% |
| Return on Equity (ttm) | -60.51% |
Income Statement
| Revenue (ttm) | 26K HKD |
| Revenue Per Share (ttm) | 0 HKD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 26K HKD |
| EBITDA | -88961000 HKD |
| Net Income Avi to Common (ttm) | -88299000 HKD |
| Diluted EPS (ttm) | -9.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 105.23M HKD |
| Total Cash Per Share (mrq) | 1.2 HKD |
| Total Debt (mrq) | 39.9M HKD |
| Total Debt/Equity (mrq) | 35.76 HKD |
| Current Ratio (mrq) | 8.241 |
| Book Value Per Share (mrq) | 1.39 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -88708000 HKD |
| Levered Free Cash Flow (ttm) | -74517128 HKD |
Profile of Sirnaomics Ltd.
| Country | Hong Kong |
| State | MD |
| City | Germantown |
| Address | 20511 Seneca Meadows Parkway |
| ZIP | 20876 |
| Phone | 301 740 1730 |
| Website | https://www.sirnaomics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 222 |
Sirnaomics Ltd., an RNA therapeutics biopharmaceutical company, discovers and develops product candidates for indications with medical needs in the United Sates, the People's Republic of China, and Hong Kong. Its lead product candidates include STP705 for the treatment cutaneous squamous cell carcinoma in situ; basal cell carcinoma; cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; keloid scarless healing, hypertrophic scarring, and fat remodeling. The company's lead product candidates also comprise STP707 to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, etc.; metastatic cutaneous squamous cell carcinoma; non-small cell lung cancer; liver fibrosis; and lung fibrosis. It also develops STP355 for the treatment of pan cancer; STP369 to treat head and neck/bladder cancer; STP779 for the treatment of liver/lung/pancreatic cancer; STP702 for the treatment of influenza; RIM730 COVID-19 vaccine; and STP122G to treat anticoagulation/thrombosis. In addition, the company is developing STP125G to treat hypertriglyceridemia; and STP144G for the treatment of complement-mediated diseases. Sirnaomics Ltd. was founded in 2007 and is headquartered in Germantown, Maryland.
Q&A For Sirnaomics Ltd. Stock
What is a current 2257.HK stock price?
Sirnaomics Ltd. 2257.HK stock price today per share is 5.99 HKD.
How to purchase Sirnaomics Ltd. stock?
You can buy 2257.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sirnaomics Ltd.?
The stock symbol or ticker of Sirnaomics Ltd. is 2257.HK.
Which industry does the Sirnaomics Ltd. company belong to?
The Sirnaomics Ltd. industry is Biotechnology.
How many shares does Sirnaomics Ltd. have in circulation?
The max supply of Sirnaomics Ltd. shares is 87.64M.
What is Sirnaomics Ltd. Price to Earnings Ratio (PE Ratio)?
Sirnaomics Ltd. PE Ratio is now.
What was Sirnaomics Ltd. earnings per share over the trailing 12 months (TTM)?
Sirnaomics Ltd. EPS is -8.07 HKD over the trailing 12 months.
Which sector does the Sirnaomics Ltd. company belong to?
The Sirnaomics Ltd. sector is Healthcare.
Sirnaomics Ltd. 2257.HK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}